pharmaphorum3d
FDA clears Pfizer's Prevnar 20 for adults, as Merck rival nears decision
The Prevnar 20 approval comes a few weeks ahead of an FDA decision on Merck's V114, which was granted a priority review by the regulator in January for the prevention of IPD in adults.
pharmaphorum6d
Shot in the arm for Affinivax as it challenges Pfizer's Prevnar
Pfizer is fighting back with the approval of its new Prevnar 20 shot last month, covering 20 serotypes, but ASP3772 is attempting to go even further with coverage of 24 serotypes thanks to ...
Zacks Investment Research on MSN4d
Merck Gets EC Nod for 21-Valent Pneumococcal Jab Capvaxive
Merck MRK announced that the European Commission (“EC”) has approved its 21-valent pneumococcal conjugate vaccine (“PCV”), ...
Hosted on MSN4mon
Pfizer's enhanced pneumococcal vaccine arriving in Korea next year
[PFIZER KOREA] Pfizer aims to release its latest pneumococcal vaccine, Prevnar 20, early next year in Korea. Prevnar, suitable for all individuals six weeks and older, offers protection against ...